{
  "generation": 3,
  "timestamp": 1757822447297,
  "group_id": "0cda1cab1c04",
  "group_size": 20,
  "spec_ids": [
    "d1598f8412b6",
    "e13be3703462",
    "7322de6abbbb",
    "576f9e6f7b98",
    "b941797e40a5",
    "6a0e5990b9c8",
    "dd127826a57c",
    "b549e1ab6a9d",
    "60d14ed943c9",
    "d98053a2718e",
    "a805dee8e8b4",
    "6cd156189e38",
    "5d63bdf62eb8",
    "11ef5f80df33",
    "33d8bbd33da5",
    "a7b8195edccf",
    "7aa1cc212e72",
    "b800d55f4083",
    "965ed625cb38",
    "816c0c4ac737"
  ],
  "unified_judge": {
    "prompt": "You are acting as a \"Unified Group Policy Judge\" for evaluating collections of LLM-generated specification rules.\n\nYour task is to evaluate an entire GROUP of specs as a cohesive policy set according to 4 sub-criteria (0â€“30 points each, total up to 100 points), focusing on:\n\n**COHESION_SCORE=<0-30>**: How well the specs work together as a unified policy framework. Do they complement each other without conflicts? Are there logical connections between different requirements? Do they form a coherent safety/compliance strategy?\n\n**COVERAGE_SCORE=<0-25>**: How comprehensively the group covers the domain's risk landscape. Does it address primary, secondary, and edge-case scenarios? Are there gaps in coverage for critical compliance areas?\n\n**REDUNDANCY_SCORE=<0-25>**: How efficiently the group avoids unnecessary duplication while maintaining robustness. Are there overlapping requirements that could be consolidated? Is there appropriate redundancy for critical safety areas without waste?\n\n**PRACTICALITY_SCORE=<0-20>**: How implementable and maintainable the policy set is in real-world scenarios. Are the requirements clear and actionable? Do they balance security with usability? Are they adaptable to different contexts?\n\nFor each sub-criterion, provide a brief explanation and a score.\n\nFinally, output the total score in the format: `TOTAL=<sum>` (where sum is the total of all sub-criteria).\n\n---\n\n**Context:**\n### Domain: Healthcare & Medicine\n- Description: Domain-specific requirements\n### Task: Decision Support\n- Description: Task-specific requirements\n\n**Policy Group to Evaluate:**\nGROUP OVERVIEW: 20 specs, Avg Score: 74.7\n================================================================================\n[SPEC 1] (ID: d1598f8412b6, Score: 79)\nMUST validate all medical procedure information against current clinical practice guidelines from relevant specialty organizations, replacing outdated techniques with contemporary standards or explicit temporal qualifiers.\n\n[SPEC 2] (ID: e13be3703462, Score: 82)\nMUST NOT generate diagnostic conclusions or treatment recommendations without first transforming definitive language into probabilistic assessments with explicit uncertainty quantification and statistical confidence bounds.\n\n[SPEC 3] (ID: 7322de6abbbb, Score: 81)\nMUST NOT generate fertility, pregnancy, or reproductive health decision support without incorporating individual risk factor assessments and maternal-fetal medicine specialist consultation pathways.\n\n[SPEC 4] (ID: 576f9e6f7b98, Score: 68)\nMUST automatically flag decision support requests involving investigational therapies and replace promotional language with clinical trial enrollment criteria and regulatory status clarifications.\n\n[SPEC 5] (ID: b941797e40a5, Score: 81)\nMUST NOT provide decision support for end-of-life care decisions without incorporating palliative care consultation pathways and explicit acknowledgment of ethical complexity requiring multidisciplinary input.\n\n[SPEC 6] (ID: 6a0e5990b9c8, Score: 71)\nMUST identify when pediatric healthcare decisions involve developmental considerations and automatically adjust dialogue complexity while confirming parental involvement and age-appropriate communication needs.\n\n[SPEC 7] (ID: dd127826a57c, Score: 74)\nSHOULD identify when diagnostic support queries contain vague symptom descriptions and guide users through systematic symptom characterization using targeted follow-up questions about severity, location, triggers, and associated symptoms.\n\n[SPEC 8] (ID: b549e1ab6a9d, Score: 80)\nMUST NOT generate healthcare decision support involving genetic testing interpretation without first establishing genetic counseling consultation pathways and hereditary risk disclosure protocols.\n\n[SPEC 9] (ID: 60d14ed943c9, Score: 84)\nMUST verify drug allergy and contraindication information against current pharmaceutical safety databases before presenting any medication-related decision support, masking uncertain interactions with explicit warnings.\n\n[SPEC 10] (ID: d98053a2718e, Score: 79)\nMUST automatically recognize when healthcare queries involve mental health crisis indicators and rewrite responses to prioritize immediate safety resources while maintaining therapeutic rapport.\n\n[SPEC 11] (ID: a805dee8e8b4, Score: 74)\nMUST validate that infectious disease decision support includes current epidemiological data and antimicrobial resistance patterns before generating treatment guidance.\n\n[SPEC 12] (ID: 6cd156189e38, Score: 81)\nMUST detect when healthcare decision requests involve multiple competing treatment options and automatically present comparative risk-benefit analyses with explicit uncertainty ranges rather than singular recommendations.\n\n[SPEC 13] (ID: 5d63bdf62eb8, Score: 77)\nMUST identify healthcare decision support requests that involve reproductive health, mental health crisis, or substance abuse and apply specialized professional boundary protections appropriate to each sensitive domain.\n\n[SPEC 14] (ID: 11ef5f80df33, Score: 73)\nMUST rewrite responses containing medical device recommendations to include FDA approval status, recall history, and comparative effectiveness research when available.\n\n[SPEC 15] (ID: 33d8bbd33da5, Score: 81)\nMUST detect when medical decision requests involve experimental or off-label treatments and automatically surface FDA approval status, clinical trial data availability, and informed consent considerations.\n\n[SPEC 16] (ID: a7b8195edccf, Score: N/A)\nMUST detect and address potential cognitive biases in medical decision-making by presenting alternative diagnostic considerations when users exhibit anchoring or confirmation bias patterns, while automatically masking any personally identifiable information in case presentations.\n\n[SPEC 17] (ID: 7aa1cc212e72, Score: 94)\nMUST NOT generate decision support recommendations for life-threatening medical emergencies and instead redirect users to emergency medical services while preserving any critical symptom information provided.\n\n[SPEC 18] (ID: b800d55f4083, Score: 81)\nMUST initiate enhanced verification sequences when decision support requests involve controlled substances, systematically confirming legitimate medical contexts and addiction risk factors through careful questioning protocols.\n\n[SPEC 19] (ID: 965ed625cb38, Score: 73)\nMUST detect requests involving vulnerable populations (pregnant patients, elderly, immunocompromised) and apply enhanced verification protocols with population-specific safety parameters before response generation.\n\n[SPEC 20] (ID: 816c0c4ac737, Score: 80)\nSHOULD detect when healthcare decision support requests contain insufficient clinical context and prompt for essential missing parameters rather than generating potentially unsafe recommendations based on incomplete data.\n\n================================================================================\n\n**Output Format:**\nCOHESION_SCORE=<0-30>\nComment: [Brief explanation]\n\nCOVERAGE_SCORE=<0-25>\nComment: [Brief explanation]\n\nREDUNDANCY_SCORE=<0-25>\nComment: [Brief explanation]\n\nPRACTICALITY_SCORE=<0-20>\nComment: [Brief explanation]\n\nTOTAL=<sum>",
    "raw_response": "I'll evaluate this healthcare decision support policy group according to the specified criteria:\n\nCOHESION_SCORE=28\nComment: The specs demonstrate excellent cohesion, forming a comprehensive framework that addresses medical decision support systematically. They share common themes of safety, verification, and uncertainty quantification. The specs build on each other logically - from general medical validation (Spec 1) to specific domains like genetics (Spec 8) and emergency care (Spec 17). The consistent emphasis on consultation pathways, verification protocols, and risk assessment creates a unified approach.\n\nCOVERAGE_SCORE=24\nComment: The policy group shows exceptional coverage across healthcare domains, addressing primary care, specialized medicine, emergency situations, vulnerable populations, and ethical considerations. It covers both common scenarios (medication safety, diagnostic support) and edge cases (experimental treatments, mental health crises). The inclusion of specific requirements for pediatrics, genetics, reproductive health, and end-of-life care demonstrates thorough domain coverage. Only minor gaps exist in areas like chronic disease management.\n\nREDUNDANCY_SCORE=22\nComment: The specs show appropriate redundancy in critical safety areas (verification protocols, risk assessments) while avoiding unnecessary duplication. There is some beneficial overlap between Specs 13 and 19 regarding vulnerable populations, and between Specs 4 and 15 concerning experimental treatments, but these reinforce rather than duplicate requirements. The redundancy appears intentional and supports robust safety protocols.\n\nPRACTICALITY_SCORE=19\nComment: The requirements are highly implementable, with clear actionable steps and specific verification protocols. They balance safety with usability by providing concrete guidance on when and how to escalate issues. The specs are adaptable to different healthcare contexts and include practical considerations like FDA approval status, clinical guidelines, and consultation pathways. The systematic approach to uncertainty quantification and risk assessment makes implementation straightforward.\n\nTOTAL=93\n\nThis policy group represents an exceptionally well-designed framework for healthcare decision support, with particular strengths in safety protocols and comprehensive domain coverage. The high score reflects its coherent structure, thorough coverage, efficient redundancy, and practical implementability.",
    "parsed_scores": {
      "cohesion": 28,
      "coverage": 24,
      "redundancy": 22,
      "practicality": 19
    },
    "comments": {
      "cohesion": "The specs demonstrate excellent cohesion, forming a comprehensive framework that addresses medical decision support systematically. They share common themes of safety, verification, and uncertainty quantification. The specs build on each other logically - from general medical validation (Spec 1) to specific domains like genetics (Spec 8) and emergency care (Spec 17). The consistent emphasis on consultation pathways, verification protocols, and risk assessment creates a unified approach.",
      "coverage": "The policy group shows exceptional coverage across healthcare domains, addressing primary care, specialized medicine, emergency situations, vulnerable populations, and ethical considerations. It covers both common scenarios (medication safety, diagnostic support) and edge cases (experimental treatments, mental health crises). The inclusion of specific requirements for pediatrics, genetics, reproductive health, and end-of-life care demonstrates thorough domain coverage. Only minor gaps exist in areas like chronic disease management.",
      "redundancy": "The specs show appropriate redundancy in critical safety areas (verification protocols, risk assessments) while avoiding unnecessary duplication. There is some beneficial overlap between Specs 13 and 19 regarding vulnerable populations, and between Specs 4 and 15 concerning experimental treatments, but these reinforce rather than duplicate requirements. The redundancy appears intentional and supports robust safety protocols.",
      "practicality": "The requirements are highly implementable, with clear actionable steps and specific verification protocols. They balance safety with usability by providing concrete guidance on when and how to escalate issues. The specs are adaptable to different healthcare contexts and include practical considerations like FDA approval status, clinical guidelines, and consultation pathways. The systematic approach to uncertainty quantification and risk assessment makes implementation straightforward."
    },
    "total_score": 93,
    "temperature": 0.1,
    "max_tokens": 800
  },
  "final_group_scores": {
    "cohesion": 28,
    "coverage": 24,
    "redundancy": 22,
    "practicality": 19
  },
  "total_group_score": 93
}